Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications
Materials Today Bio · 2024-06 · 26 · 101059
DOI: 10.1016/j.mtbio.2024.101059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2024-06. Verfasst von Kest Verstappen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry-Regenerative Biomaterials, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 EX, Nijmegen, t…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Horizon 2020, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Despite the immense need for effective treatment of spinal cord injury (SCI), no successful repair strategy has yet been clinically implemented. Multifunctional biomaterials, based on porcine adipose tissue-derived extracellular matrix (adECM) and reduced graphene oxide (rGO), were recently shown to stimulate in vitro neural stem cell growth and differentiation. Nevertheless, their functional performance in clinically more relevant in vivo conditions remains largely unknown. Before clinical application of these adECM-rGO nanocomposites can be considered, a rigorous assessment of the cytotoxicity and biocompatibility of these biomaterials is required. For instance, xenogeneic adECM scaffolds could still harbour potential immunogenicity following decellularization. In addition, the toxicity of rGO has been studied before, yet often in experimental settings that do not bear relevance to regenerative medicine. Therefore, the present study aimed to assess both the in vitro as well as in vivo safety of adECM and adECM-rGO scaffolds. First, pulmonary, renal and hepato-cytotoxicity as well as macrophage polarization studies showed that scaffolds were benign invitro. Then, a laminectomy was performed at the 10th thoracic vertebra, and scaffolds were implanted directly contacting the spinal cord. For a total duration of 6 weeks, animal welfare was not negatively affected. Histological analysis demonstrated the degradation of adECM scaffolds and subsequent tissue remodeling. Graphene-based scaffolds showed a very limited fibrous encapsulation, while rGO sheets were engulfed by foreign body giant cells. Furthermore, all scaffolds were infiltrated by macrophages, which were largely polarized towards a pro-regenerative phenotype. Lastly, organ-specific histopathology and biochemical analysis of blood did not reveal any adverse effects. In summary, both adECM and adECM-rGO implants were biocompatible upon laminectomy while establishing a pro-regenerative microenvironment, which justifies further research on their therapeutic potential for treatment of SCI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dentistry-Regenerative Biomaterials, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 EX, Nijmegen, the Netherlands.
- Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040, Madrid, Spain.
- Centre for Mechanical Technology and Automation (TEMA), Intelligent Systems Associate Laboratory (LASI), Department of Mechanical Engineering, University of Aveiro, 3810-193, Aveiro, Portugal.
- TECNALIA, Basque Research and Technology Alliance (BRTA), E20009, Donostia-San Sebastian, Spain.
- Department of Biochemistry and Molecular Biology, Faculty of Chemistry, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040, Madrid, Spain.
- Department of Microbiology and Parasitology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040, Madrid, Spain.
Förderung
- Horizon 2020
- Horizon 2020 Framework Programme
Zitieren
APA
Verstappen, K., Klymov, A., Cicuéndez, M., da Silva, D. M., Barroca, N., Fernández-San-Argimiro, F. J., Madarieta, I., Casarrubios, L., Feito, M. J., Diez-Orejas, R., Ferreira, R., Leeuwenburgh, S. C. G., Portolés, M. T., Marques, P. A. A. P., & Walboomers, X. F. (2024). Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications. Materials Today Bio, 26, 101059. https://doi.org/10.1016/j.mtbio.2024.101059
Vancouver
Verstappen K, Klymov A, Cicuéndez M, da Silva DM, Barroca N, Fernández-San-Argimiro FJ, et al. Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications. Materials Today Bio. 2024;26:101059. doi:10.1016/j.mtbio.2024.101059
BibTeX
@article{Verstappen2024,
author = {Verstappen, Kest and Klymov, Alexey and Cicuéndez, Mónica and da Silva, Daniela M and Barroca, Nathalie and Fernández-San-Argimiro, Francisco-Javier and Madarieta, Iratxe and Casarrubios, Laura and Feito, María José and Diez-Orejas, Rosalía and Ferreira, Rita and Leeuwenburgh, Sander C G and Portolés, María Teresa and Marques, Paula A A P and Walboomers, X Frank},
title = {Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications},
journal = {Materials Today Bio},
year = {2024},
volume = {26},
pages = {101059},
doi = {10.1016/j.mtbio.2024.101059}
}
EUVIMED